Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis

ClinicalTrials.gov ID: NCT03398135

Public ClinicalTrials.gov record NCT03398135. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 1:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects With Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate safety and efficacy of risankizumab in participants with ulcerative colitis (UC) in participants who responded to induction treatment with risankizumab in a prior AbbVie study of risankizumab in UC. This study consists of three sub-studies and a Continuous Treatment Extension (CTE): Substudy 1 is a 52-week, randomized, double-blind, placebo-controlled maintenance study; Substudy 2 is 52-week, randomized, exploratory maintenance study; and Substudy 3 is an open-label long-term extension study for participants who completed Substudy 1 or 2, or participants who responded to induction treatment in Study M16-067 with no final endoscopy due to the Covid-19 pandemic or due to the geopolitical conflict in Ukraine and surrounding impacted regions. The CTE is an open-label extension for Substudy 3 completers to ensure continuous treatment with risankizumab until such time that risankizumab becomes commercially available and/or the subject can access treatment locally.

Study identification

NCT ID
NCT03398135
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
1,242 participants

Conditions and interventions

Eligibility (public fields only)

Age range
16 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 28, 2018 (Actual)
Primary completion
Sep 2028 (Estimated)
Completion
Feb 2029 (Estimated)
Last update posted
Jan 20, 2026

2018 – 2029

United States locations

U.S. sites
78
U.S. states
26
U.S. cities
63
Facility City State ZIP Site status
Southern California Res. Ctr. /ID# 169659 Coronado California 92118-1408 —
Hoag Memorial Hosp Presbyterian /ID# 218347 Irvine California 92618 —
UC San Diego Health System /ID# 160430 La Jolla California 92037 —
United Medical Doctors /ID# 158574 Los Alamitos California 90720-3309 —
Cedars-Sinai Medical Center /ID# 163848 Los Angeles California 90048 —
Gastrointestinal Biosciences Clinical Trials, LLC /ID# 200934 Los Angeles California 90067-2001 —
UCSF Medical Center - Mount Zion /ID# 201209 San Francisco California 94115 —
Peak Gastroenterology Associates, PC /ID# 165838 Colorado Springs Colorado 80907 —
Rocky Mountain Pediatric Gastroenterology /ID# 207173 Lone Tree Colorado 80124-6798 —
Duplicate_Medical Research Center of CT /ID# 160287 Hamden Connecticut 06518 —
Yale Univ Digestive Diseases /ID# 213265 New Haven Connecticut 06510 —
South Lake Pain Institute, Inc /ID# 162859 Clermont Florida 34711 —
Ctr for Advanced Gastroenterol /ID# 202820 Maitland Florida 32751-6108 —
University of Miami /ID# 160456 Miami Florida 33136 —
Coral Research Clinic /ID# 158608 Miami Florida 33186-4643 —
South Florida Research Ph I-IV, Inc. /ID# 161844 Miami Florida 33193 —
Gastroenterology Group Naples /ID# 165210 Naples Florida 34102 —
Advanced Research Institute, Inc /ID# 161945 New Port Richey Florida 34653 —
Advent Health /ID# 160393 Orlando Florida 32803 —
Endoscopic Research, Inc. /ID# 206709 Orlando Florida 32803 —
Omega Research Group /ID# 203105 Orlando Florida 32808 —
Duplicate_Lenus Research & Medical Group /ID# 169727 Sweetwater Florida 33172 —
Clinical Research Trials of Florida, Inc. /ID# 201794 Tampa Florida 33607 —
Duplicate_AdventHealth Tampa /ID# 170482 Tampa Florida 33613-4680 —
Gastroenterology Associates of Central Georgia, LLC /ID# 160513 Macon Georgia 31201 —
The University of Chicago Medical Center /ID# 160511 Chicago Illinois 60637-1443 —
DM Clinical Research/Southwest /ID# 165009 Oak Lawn Illinois 60453 —
Indiana University /ID# 167250 Indianapolis Indiana 46202 —
Univ Kansas Med Ctr /ID# 226601 Kansas City Kansas 66160 —
Cotton O'Neil Clinical Research Center, Digestive Health /ID# 160367 Topeka Kansas 66606 —
Duplicate_Robley Rex VA Medical Center /ID# 218647 Louisville Kentucky 40206 —
Houma Digestive Health Special /ID# 158377 Houma Louisiana 70360 —
Delricht Research /ID# 206817 New Orleans Louisiana 70115 —
Nola Research Works, LLC /ID# 161356 New Orleans Louisiana 70115 —
Louisiana Research Center, LLC /ID# 201205 Shreveport Louisiana 71105-6800 —
Massachusetts General Hospital - Crohn's and Colitis Center /ID# 164257 Boston Massachusetts 02114 —
University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 159430 Ann Arbor Michigan 48109 —
Clin Res Inst of Michigan, LLC /ID# 160300 Chesterfield Michigan 48047 —
Mayo Clinic - Rochester /ID# 200455 Rochester Minnesota 55905-0001 —
Quality Clinical Research Inc. /ID# 167312 Omaha Nebraska 68114-3723 —
Weill Cornell Medicine /ID# 165884 New York New York 10022 —
Columbia Univ Medical Center /ID# 161929 New York New York 10032-3725 —
Lenox Hill Hospital /ID# 168469 New York New York 10075 —
Manhattan Clinical Research, LLC /ID# 211803 New York New York 10279 —
Duplicate_DiGiovanna Institute for Medical Education & Research /ID# 171128 North Massapequa New York 11758 —
Duplicate_University of Rochester Medical Center /ID# 161660 Rochester New York 14642 —
Atrium Health Carolinas Medical Center /ID# 158543 Charlotte North Carolina 28203 —
Plains Clinical Research Center, LLC /ID# 169729 Fargo North Dakota 58104-5925 —
Cleveland Clinic Main Campus /ID# 209235 Cleveland Ohio 44195 —
The Ohio State University /ID# 164713 Columbus Ohio 43210 —
Optimed Research, Ltd. /ID# 167112 Columbus Ohio 43235 —
Great Lakes Gastroenterology Research, LLC /ID# 201778 Mentor Ohio 44060-6211 —
ProMedica Physicians Digestive Healthcare /ID# 215622 Sylvania Ohio 43560-2767 —
Digestive Disease Specialists /ID# 170777 Oklahoma City Oklahoma 73112 —
Adult Gastroenterology Associates - Gen 1 Research /ID# 208873 Tulsa Oklahoma 74136-7823 —
Penn State Milton S. Hershey Medical Center /ID# 230474 Hershey Pennsylvania 17033-2360 —
University of Pennsylvania /ID# 166262 Philadelphia Pennsylvania 19104-5502 —
Digestive Disease Associates, LTD - Wyomissing /ID# 232406 Wyomissing Pennsylvania 19610 —
Gastroenterology Associates, P.A. of Greenville /ID# 160457 Greenville South Carolina 29607 —
Gastro One /ID# 160373 Cordova Tennessee 38018 —
Duplicate_East Tennessee Research Institute /ID# 168744 Johnson City Tennessee 37604 —
Vanderbilt University Medical Center /ID# 160567 Nashville Tennessee 37232-0011 —
Inquest Clinical Research /ID# 165686 Baytown Texas 77521-2415 —
Texas Digestive Disease Consultants /ID# 209951 Cedar Park Texas 78613-5028 —
GI Alliance /ID# 209799 Cedar Park Texas 78613 —
Digestive Health Associates of Texas (DHAT) Research Institute - Garland /ID# 158235 Garland Texas 75044 —
Vilo Research Group Inc /ID# 207657 Houston Texas 77017-2337 —
Baylor College of Medicine /ID# 158230 Houston Texas 77030 —
Centex Studies, Inc. - Houston /ID# 201221 Houston Texas 77058 —
Duplicate_Caprock Gastro Research, LLC /ID# 215433 Lubbock Texas 79424-3017 —
Clinical Associates in Research Therapeutics of America, LLC /ID# 161364 San Antonio Texas 78212 —
Southern Star Research Institute, LLC /ID# 168774 San Antonio Texas 78229-5390 —
Baylor Scott & White Center for Diagnostic Medicine /ID# 204132 Temple Texas 76508 —
Tyler Research Institute, LLC /ID# 166799 Tyler Texas 75701 —
Gastro Health & Nutrition - Victoria /ID# 164308 Victoria Texas 77904 —
Advanced Research Institute /ID# 160465 Ogden Utah 84405 —
Gastroenterology Consultants of Southwest Virginia /ID# 218142 Roanoke Virginia 24014-1372 —
Virginia Mason Hospital & Medical Center /ID# 160432 Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 348 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03398135, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 20, 2026 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03398135 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →